85 related articles for article (PubMed ID: 23046363)
21. Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury.
Soulis T; Thallas V; Youssef S; Gilbert RE; McWilliam BG; Murray-McIntosh RP; Cooper ME
Diabetologia; 1997 Jun; 40(6):619-28. PubMed ID: 9222639
[TBL] [Abstract][Full Text] [Related]
22. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
Liu XP; Pang YJ; Zhu WW; Zhao TT; Zheng M; Wang YB; Sun ZJ; Sun SJ
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797
[TBL] [Abstract][Full Text] [Related]
23. Alagebrium reduces glomerular fibrogenesis and inflammation beyond preventing RAGE activation in diabetic apolipoprotein E knockout mice.
Watson AM; Gray SP; Jiaze L; Soro-Paavonen A; Wong B; Cooper ME; Bierhaus A; Pickering R; Tikellis C; Tsorotes D; Thomas MC; Jandeleit-Dahm KA
Diabetes; 2012 Aug; 61(8):2105-13. PubMed ID: 22698914
[TBL] [Abstract][Full Text] [Related]
24. Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor.
Sourris KC; Morley AL; Koitka A; Samuel P; Coughlan MT; Penfold SA; Thomas MC; Bierhaus A; Nawroth PP; Yamamoto H; Allen TJ; Walther T; Hussain T; Cooper ME; Forbes JM
Diabetologia; 2010 Nov; 53(11):2442-51. PubMed ID: 20631980
[TBL] [Abstract][Full Text] [Related]
25. The protective effect of Salvia miltiorrhiza in an animal model of early experimentally induced diabetic nephropathy.
Lee SH; Kim YS; Lee SJ; Lee BC
J Ethnopharmacol; 2011 Oct; 137(3):1409-14. PubMed ID: 21856399
[TBL] [Abstract][Full Text] [Related]
26. Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products.
Schwenger V; Morath C; Salava A; Amann K; Seregin Y; Deppisch R; Ritz E; Bierhaus A; Nawroth PP; Zeier M
J Am Soc Nephrol; 2006 Jan; 17(1):199-207. PubMed ID: 16319192
[TBL] [Abstract][Full Text] [Related]
27. Receptor for advanced glycation end products is a promising target of diabetic nephropathy.
Yamamoto Y; Doi T; Kato I; Shinohara H; Sakurai S; Yonekura H; Watanabe T; Myint KM; Harashima A; Takeuchi M; Takasawa S; Okamoto H; Hashimoto N; Asano M; Yamamoto H
Ann N Y Acad Sci; 2005 Jun; 1043():562-6. PubMed ID: 16037279
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin II upregulates RAGE expression on podocytes: role of AT2 receptors.
Rüster C; Bondeva T; Franke S; Tanaka N; Yamamoto H; Wolf G
Am J Nephrol; 2009; 29(6):538-50. PubMed ID: 19129693
[TBL] [Abstract][Full Text] [Related]
29. Podocytes of AT2 receptor knockout mice are protected from angiotensin II-mediated RAGE induction.
Rüster C; Franke S; Wenzel U; Schmidthaupt R; Fraune C; Krebs C; Wolf G
Am J Nephrol; 2011; 34(4):309-17. PubMed ID: 21846974
[TBL] [Abstract][Full Text] [Related]
30. Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression.
Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
Horm Metab Res; 2012 Nov; 44(12):891-5. PubMed ID: 22864903
[TBL] [Abstract][Full Text] [Related]
31. Short-term effects of dietary advanced glycation end products in rats.
Poulsen MW; Andersen JM; Hedegaard RV; Madsen AN; Krath BN; Monošík R; Bak MJ; Nielsen J; Holst B; Skibsted LH; Larsen LH; Dragsted LO
Br J Nutr; 2016 Feb; 115(4):629-36. PubMed ID: 26824730
[TBL] [Abstract][Full Text] [Related]
32. Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice.
Fan Q; Liao J; Kobayashi M; Yamashita M; Gu L; Gohda T; Suzuki Y; Wang LN; Horikoshi S; Tomino Y
Nephrol Dial Transplant; 2004 Dec; 19(12):3012-20. PubMed ID: 15574998
[TBL] [Abstract][Full Text] [Related]
33. Galectin-3/AGE-receptor 3 knockout mice show accelerated AGE-induced glomerular injury: evidence for a protective role of galectin-3 as an AGE receptor.
Iacobini C; Menini S; Oddi G; Ricci C; Amadio L; Pricci F; Olivieri A; Sorcini M; Di Mario U; Pesce C; Pugliese G
FASEB J; 2004 Nov; 18(14):1773-5. PubMed ID: 15361471
[TBL] [Abstract][Full Text] [Related]
34. Expression of receptors for advanced glycosylated end-products in renal disease.
Abel M; Ritthaler U; Zhang Y; Deng Y; Schmidt AM; Greten J; Sernau T; Wahl P; Andrassy K; Ritz E
Nephrol Dial Transplant; 1995; 10(9):1662-7. PubMed ID: 8559486
[TBL] [Abstract][Full Text] [Related]
35. Advanced glycation end product homeostasis: exogenous oxidants and innate defenses.
Vlassara H; Uribarri J; Cai W; Striker G
Ann N Y Acad Sci; 2008 Apr; 1126():46-52. PubMed ID: 18448795
[TBL] [Abstract][Full Text] [Related]
36. Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression.
Morris-Rosenfeld S; Blessing E; Preusch MR; Albrecht C; Bierhaus A; Andrassy M; Nawroth PP; Rosenfeld ME; Katus HA; Bea F
Eur J Clin Invest; 2011 Nov; 41(11):1164-71. PubMed ID: 21418204
[TBL] [Abstract][Full Text] [Related]
37. Angelica acutiloba root alleviates advanced glycation end-product-mediated renal injury in streptozotocin-diabetic rats.
Liu IM; Tzeng TF; Liou SS; Chang CJ
J Food Sci; 2011 Sep; 76(7):H165-74. PubMed ID: 22417553
[TBL] [Abstract][Full Text] [Related]
38. The alternative crosstalk between RAGE and nitrative thioredoxin inactivation during diabetic myocardial ischemia-reperfusion injury.
Liu Y; Qu Y; Wang R; Ma Y; Xia C; Gao C; Liu J; Lian K; Xu A; Lu X; Sun L; Yang L; Lau WB; Gao E; Koch W; Wang H; Tao L
Am J Physiol Endocrinol Metab; 2012 Oct; 303(7):E841-52. PubMed ID: 22829582
[TBL] [Abstract][Full Text] [Related]
39. Topical treatment with anti-oxidants and Au nanoparticles promote healing of diabetic wound through receptor for advance glycation end-products.
Chen SA; Chen HM; Yao YD; Hung CF; Tu CS; Liang YJ
Eur J Pharm Sci; 2012 Dec; 47(5):875-83. PubMed ID: 22985875
[TBL] [Abstract][Full Text] [Related]
40. Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes.
Gu L; Hagiwara S; Fan Q; Tanimoto M; Kobata M; Yamashita M; Nishitani T; Gohda T; Ni Z; Qian J; Horikoshi S; Tomino Y
Nephrol Dial Transplant; 2006 Feb; 21(2):299-313. PubMed ID: 16263740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
